Home > Hugh Calkins, AF Symposium 2021: the STOP Persistent AF Clinical Trial
Atrial Fibrillation

Hugh Calkins, AF Symposium 2021: the STOP Persistent AF Clinical Trial

Published Online: February 5th 2021

We spoke to Professor Hugh Calkins (Johns Hopkins Hospital, Baltimore, MD, USA) about the STOP Persistent AF Clinical Trial (NCT03012841).


  1. Could you tell us a little about the aims and design of the STOP Persistent AF clinical trial? (0.13)
  2. What were the findings of the study? (0.43)
  3. What are their implications for clinical practice? (2.19)

Speaker disclosures: Professor Hugh Calkins is a consultant and/or has received honoraria from Atricure, Biosense Webster, Abbott, Medtronic and Ablacon.

Commissioned, edited and funded by Touch Medical Media.

Filmed during a remote video call with Professor Hugh Calkins as a highlight of the AF Symposium, January 2021.

Share this Video
Related Videos In Atrial Fibrillation
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar